Rubedo Life Sciences is a clinical-stage biotechnology company discovering and developing precision medicines that target the biological drivers of aging and age-related diseases. Its proprietary ALEMBIC drug-discovery platform identifies and validates senescent ("zombie") cells that accumulate with age and drive chronic disease, enabling the… - View it on GitHub